These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27150163)

  • 1. The prevalence and risk factors of the metabolic syndrome in inpatients with intellectual disability.
    Room B; Timmermans O; Roodbol P
    J Intellect Disabil Res; 2016 Jun; 60(6):594-605. PubMed ID: 27150163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of sociodemographic and lifestyle factors and diet habits with metabolic syndrome (MetS) among three ethnic groups of the Malaysian population.
    Iqbal SP; Ramadas A; Fatt QK; Shin HL; Onn WY; Kadir KA
    PLoS One; 2020; 15(3):e0224054. PubMed ID: 32191727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 3-year follow-up study on cardiovascular disease and mortality in older people with intellectual disabilities.
    de Winter CF; van den Berge AP; Schoufour JD; Oppewal A; Evenhuis HM
    Res Dev Disabil; 2016; 53-54():115-26. PubMed ID: 26874209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Predictors of Metabolic Syndrome in People With Schizophrenia in Inpatient Rehabilitation Wards.
    Yang CY; Lo SC; Peng YC
    Biol Res Nurs; 2016 Oct; 18(5):558-66. PubMed ID: 27268516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and short-term heart rate variability in adults with intellectual disabilities.
    Chang YW; Lin JD; Chen WL; Yen CF; Loh CH; Fang WH; Wu LW
    Res Dev Disabil; 2012; 33(6):1701-7. PubMed ID: 22684003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review.
    Wysokiński A; Kowman M; Kłoszewska I
    Psychiatr Danub; 2012 Sep; 24(3):314-22. PubMed ID: 23013638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study.
    Hammoudeh S; Ghuloum S; Mahfoud Z; Yehya A; Abdulhakam A; Al-Mujalli A; Al-Zirie M; Abdel Rahman MO; Godwin A; Younes N; Hani Y; Mook-Kanamori D; Mook-Kanamori M; El Sherbiny R; Al-Amin H
    BMC Psychiatry; 2018 Mar; 18(1):81. PubMed ID: 29587717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of metabolic syndrome among hypertensive patients at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia.
    Tadewos A; Egeno T; Amsalu A
    BMC Cardiovasc Disord; 2017 Aug; 17(1):218. PubMed ID: 28789613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of cardio-metabolic risk factors among adolescents with intellectual disability.
    Wallén EF; Müllersdorf M; Christensson K; Malm G; Ekblom O; Marcus C
    Acta Paediatr; 2009 May; 98(5):853-9. PubMed ID: 19183118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in prevalence of metabolic syndrome between Japanese outpatients and inpatients with schizophrenia: A nationwide survey.
    Sugai T; Suzuki Y; Yamazaki M; Shimoda K; Mori T; Ozeki Y; Matsuda H; Sugawara N; Yasui-Furukori N; Minami Y; Okamoto K; Sagae T; Someya T
    Schizophr Res; 2016 Mar; 171(1-3):68-73. PubMed ID: 26811231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of symptoms of anxiety and depression with diabetes and cardiovascular risk factors in older people with intellectual disability.
    de Winter CF; Hermans H; Evenhuis HM; Echteld MA
    J Intellect Disabil Res; 2015 Feb; 59(2):176-85. PubMed ID: 23627768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of the metabolic syndrome in IGT subjects in a lifestyle intervention: results from the SLIM study.
    den Boer AT; Herraets IJ; Stegen J; Roumen C; Corpeleijn E; Schaper NC; Feskens E; Blaak EE
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1147-53. PubMed ID: 23462149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factors (diabetes, hypertension, hypercholesterolemia and metabolic syndrome) in older people with intellectual disability: results of the HA-ID study.
    de Winter CF; Bastiaanse LP; Hilgenkamp TI; Evenhuis HM; Echteld MA
    Res Dev Disabil; 2012; 33(6):1722-31. PubMed ID: 22699246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age, sex, and race/ethnic temporal trends in metabolic syndrome prevalence among individuals with myocardial infarction or stroke in the United States.
    Lekoubou A; Ovbiagele B; Markovic D; Sanossian N; Towfighi A
    J Neurol Sci; 2017 May; 376():24-28. PubMed ID: 28431619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structured Medication Review to Improve Pharmacotherapy in People with Intellectual Disability and Behavioural Problems.
    Scheifes A; Egberts TC; Stolker JJ; Nijman HL; Heerdink ER
    J Appl Res Intellect Disabil; 2016 Jul; 29(4):346-55. PubMed ID: 25882186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age at menarche and its association with the metabolic syndrome in Taiwan.
    Chang CJ; Lai MM; Lin CC; Liu CS; Li TC; Li CI; Lin WY
    Obes Res Clin Pract; 2016 Sep; 10 Suppl 1():S26-S34. PubMed ID: 26777792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A follow-up study of metabolic syndrome in schizophrenia.
    Yoca G; Anıl Yağcıoğlu AE; Eni N; Karahan S; Türkoğlu İ; Akal Yıldız E; Mercanlıgil SM; Yazıcı MK
    Eur Arch Psychiatry Clin Neurosci; 2020 Aug; 270(5):611-618. PubMed ID: 31030256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in Multiple Lifestyle Factors in Subjects with the Metabolic Syndrome Independently of Obesity.
    Roos V; Elmståhl S; Ingelsson E; Sundström J; Ärnlöv J; Lind L
    Metab Syndr Relat Disord; 2017 Apr; 15(3):118-123. PubMed ID: 28339343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secular Trend of Metabolic Syndrome and Its Components in a Cohort of Iranian Adults from 2001 to 2013.
    Khosravi-Boroujeni H; Sarrafzadegan N; Sadeghi M; Roohafza H; Talaei M; Ng SK; Phung H; Pourmogaddas A; Ahmed F
    Metab Syndr Relat Disord; 2017 Apr; 15(3):137-144. PubMed ID: 28135122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Syndrome Development During Aging with Special Reference to Obesity Without the Metabolic Syndrome.
    Roos V; Elmståhl S; Ingelsson E; Sundström J; Ärnlöv J; Lind L
    Metab Syndr Relat Disord; 2017 Feb; 15(1):36-43. PubMed ID: 27754771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.